These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 3633253)

  • 41. [Is modern anti-aggregation therapy effective?].
    Hladovec J
    Cas Lek Cesk; 1984 May; 123(21):630-5. PubMed ID: 6744376
    [No Abstract]   [Full Text] [Related]  

  • 42. Persantine-aspirin reinfarction study. Design, methods and baseline results. By the persantine-aspirin reinfarction study research group.
    Circulation; 1980 Sep; 62(3 Pt 2):II1-42. PubMed ID: 7408140
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Prevention of cardiovascular diseases by inhibitors of platelet aggregation (author's transl)].
    Boeynaems JM
    Rev Med Brux; 1982 Jun; 3(6):415-24. PubMed ID: 7111939
    [No Abstract]   [Full Text] [Related]  

  • 44. [Platelet antiaggregants in post-myocardial infarct patients: why, which and in what doses?].
    Mannucci PM
    G Ital Cardiol; 1983 Nov; 13(11):335-9. PubMed ID: 6667821
    [No Abstract]   [Full Text] [Related]  

  • 45. [Results of clinical studies on the effect of aggregation inhibitors in arterial diseases].
    Loew D
    Med Welt; 1979 Feb; 30(5):166-9. PubMed ID: 759804
    [No Abstract]   [Full Text] [Related]  

  • 46. [Prospects of antiaggregant therapy in prevention of atherosclerosis].
    Strano A; Novo S
    G Ital Cardiol; 1979; 9(1):5-9. PubMed ID: 396163
    [No Abstract]   [Full Text] [Related]  

  • 47. [Effect of persantin on selected platelet functions in myocardial infarct].
    Markiewicz M; Kowalewski J; Florkiewicz H; Pluta A; Koziara Z; Szponar M; Dmosyńska A
    Pol Tyg Lek; 1980 Sep; 35(35):1343-5. PubMed ID: 7433215
    [No Abstract]   [Full Text] [Related]  

  • 48. Role of platelet inhibitor therapy in myocardial infarction.
    Stein B; Fuster V
    Cardiovasc Drugs Ther; 1989 Dec; 3(6):797-813. PubMed ID: 2487543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract]   [Full Text] [Related]  

  • 50. Anti platelet agents for strokes and myocardial infarction: a critical appraisal of recent clinical trials.
    Castaldi PA
    Aust N Z J Med; 1981 Dec; 11(6):673-7. PubMed ID: 7036973
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Current status of platelet inhibitor therapy in coronary artery disease.
    Harbold NB
    Coll Works Cardiopulm Dis; 1982 May; 23():1-3. PubMed ID: 7047065
    [No Abstract]   [Full Text] [Related]  

  • 52. [Critical approach to a therapeutic trial in secondary prevention of cerebral ischemic accidents by antiaggregants].
    Guiraud-Chaumeil B
    Presse Med; 1983 Dec; 12(48):3045-8. PubMed ID: 6228912
    [No Abstract]   [Full Text] [Related]  

  • 53. Antiplatelet drugs or dicoumarol: what is the most effective prophylaxis in occlusive arterial disease?
    Poliwoda H; Avenarius HJ
    Int Angiol; 1986; 5(3):169-80. PubMed ID: 2435823
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Present status of antiaggregating agents in coronary and cerebrovascular disease prevention.
    Polli EE; Cortellaro M
    Haematologica; 1980 Jun; 65(3):361-9. PubMed ID: 6778788
    [No Abstract]   [Full Text] [Related]  

  • 55. [Clinical application and evaluation of anti-platelet agents].
    Yasunaga K
    Nihon Rinsho; 1978 Dec; 36(12):3884-94. PubMed ID: 372628
    [No Abstract]   [Full Text] [Related]  

  • 56. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
    Serebruany VL; Malinin AI; Pokov AN; Hanley DF
    Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experimental basis of platelet aggregation inhibition by acetylsalicylic acid.
    Born GV; Görög P; Begent NA
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):719-24. PubMed ID: 6083947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial.
    Serebruany VL; Malinin AI; Sane DC; Jilma B; Takserman A; Atar D; Hennekens CH
    Eur J Pharmacol; 2004 Sep; 499(3):315-24. PubMed ID: 15381054
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Platelets and prostaglandins in ischemic cardiopathy. Theoretical and practical aspects and research prospects].
    Verdecchia P
    Clin Ter; 1982 Apr; 101(2):179-94. PubMed ID: 7047054
    [No Abstract]   [Full Text] [Related]  

  • 60. Role of platelet-active drugs in coronary artery disease.
    Sherry S
    Cardiovasc Clin; 1983; 14(1):173-89. PubMed ID: 6352025
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.